US Patent Issued to VIIV HEALTHCARE UK (NO. 5) on Aug. 11 for "Inhibitors of human immunodeficiency virus replication" (Connecticut Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,699, issued on Aug. 11, was assigned to VIIV HEALTHCARE UK (NO. 5) Ltd. (Middlesex, Great Britain).

"Inhibitors of human immunodeficiency virus replication" was invented by Eric P. Gillis (Branford, Conn.) and Christiana Iwuagwu (Wallingford, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:"

The patent was filed on March 3, 2021, under Application No. 17/801,410.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netac...